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Varicella-zoster virus infects human dendritic cells (DCs). We found that VZV infection of DCs resulted in down-regulation of Fas
expression on the surface of cells. VZV ORF47 was critical for replication of virus in human immature, but not mature DCs. Immature DCs
infected with a mutant virus unable to express ORF47 expressed similar levels of a VZV immediate–early protein as cells infected with
parental virus; however, cells infected with the ORF47 mutant expressed lower levels of glycoprotein E. Thus, in the absence of ORF47
protein, there is a block in viral replication between immediate–early and late gene expression. VZV unable to express ORF47 was severely
impaired for spread of virus from DCs to melanoma cells. Infection of DCs with parental VZV resulted in a different pattern of
phosphoproteins compared with the ORF47 mutant virus. Thus, VZV ORF47 is important for replication in immature DCs and for spread to
other cells.
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Varicella-zoster virus (VZV) infects up to 90% of the
human population and is the etiologic agent of varicella
(chickenpox). Following resolution of primary infection the
virus establishes a lifelong, latent infection in the dorsal root
and cranial nerve ganglia. Reactivation of virus results in
herpes zoster (shingles). The cellular immune response is
important for controlling reactivation and for reducing the
severity of primary disease. Persons with impaired cellular
immunity are at increased risk for severe chickenpox and are
more likely to develop shingles (Gershon et al., 1997; Jura
et al., 1989). The cellular immune response to VZV includes
NK cells, T cells, and dendritic cells (DCs) (Jenkins et al.,
1999; Vossen et al., 2005).0042-6822/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.virol.2005.04.024
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E-mail address: jcohen@niaid.nih.gov (J.I. Cohen).DCs are potent antigen-presenting cells and are impor-
tant for initiating immune responses to virus infections.
Immature DCs express MHC class I and MHC class II
molecules, CD40 ligand, and costimulatory molecules such
as CD80 and CD86 (Mellman and Steinman, 2001). They
have excellent antigen-processing, but poor antigen-pre-
senting capacity. When immature DCs are stimulated by
CD40 ligand, tumor necrosis factor-a, interferon-g (IFN-
g), or interleukin 6 (IL-6), they undergo a morphologic
change and become mature DCs. Compared with imma-
ture DCs, mature DCs express higher levels of surface
CD80 and CD86 and express CD83 which increases their
ability to stimulate T cells. Unlike immature DCs, mature
DCs are excellent at both antigen processing and antigen
presentation.
There are three pathways that DCs use to present
antigens to CD8 or CD4 T cells. First, infection of DCs
with viruses leads to expression of viral proteins that are
processed into 8–10 amino acid peptides in the proteasome.
These peptides are loaded onto MHC class I molecules and05) 304 – 311
Fig. 1. Morphology of human blood monocyte-derived DCs stimulated by
LPS and IFN-g. Human monocytes were cultured in RPMI containing GM-
CSF and IL-4 for 7 days to yield immature DCs. The latter were then
incubated with LPS and IFN-g for 2 more days to yield mature DCs.
Dendrites on mature DCs are apparent by microscopy.
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T cells in a process known as the MHC class I endogenous
pathway. Second, DCs can take up apoptotic virus-infected
cells or viral proteins. These proteins and particles are
processed in endosomes, released into the cytosol for further
processing, and presented by MHC class I on the cell
surface to CD8 T cells in a process known as the MHC class
I cross-presentation pathway. Third, DCs can endocytose
viral proteins or inactivated virus in vacuoles, process the
proteins, load them onto MHC class II molecules, and
transport them to the cell surface for presentation to CD4 T
cells. This process is known as the MHC class II exogenous
pathway.
Many viruses can productively infect DCs including
human immunodeficiency virus (Granelli-Piperno et al.,
1998), cytomegalovirus (Riegler et al., 2000), herpes
simplex virus (HSV) types 1 and 2 (Jones et al., 2003;
Mikloska et al., 2001), Epstein–Barr virus (Li et al., 2002),
human herpesvirus 6 (Asada et al., 1999), and VZV
(Morrow et al., 2003).
VZV productively infects both immature and mature
DCs. Abendroth et al. (2001) showed that VZV-infected
immature DCs did not undergo apoptosis, and that the
infected cells could transfer virus to human fibroblasts or T
cells. Morrow et al. (2003) showed that VZV infection of
mature DCs impaired their ability to stimulate allogeneic T
cells.
Previous studies from our laboratory showed that VZV
mutants unable to express certain genes, such as open
reading frame 47 (ORF47) or ORF66, are impaired for
growth in human T cells, while other mutants show no
difference from parental virus (Moffat et al., 1998; Soong et
al., 2000). VZV unable to express ORF47 was even more
impaired for spread from human T cells to melanoma cells
in vitro. In the present study, we infected immature and
mature DCs with a panel of VZV mutants. We found that
VZV ORF47 is important for replication of virus in
immature, but not mature cells. In the absence of ORF47,
VZV replication is blocked between immediate–early and
late gene expression. While ORF47 is not required for
infection of DCs, it is critical for transfer of VZV from DCs
to other cells.Results
Infection of immature or mature DCs results in
down-regulation of surface Fas expression
Human immature DCs were generated from peripheral
blood monocytes by incubation with granulocyte-macro-
phage colony-stimulating factor (GM-CSF) and IL-4 for 7
days (Fig. 1, left panel). These cells were defined by their
cell surface phenotype (CD1a+ and CD83). The purity of
mature DCs was >90% as assessed by flow cytometry.
Immature DCs were then cultured for a further 2 days inmedium containing LPS and IFN-g to stimulate maturation.
The mature DCs showed dendrites on their surface (Fig. 1,
right panel) and displayed a mature DC phenotype (CD1a+
and CD83+).
Prior studies by Morrow et al. (2003) showed that VZV
infection of mature DCs results in reduced surface
expression of MHC class I, CD80, CD83, and CD86, but
no change in MHC class II, while a study by Abendroth et
al. (2001) showed that infection of immature DCs had no
effect on MHC class I, class II, or CD86. We incubated
VZV-infected immature and mature DCs with antibodies to
VZV glycoprotein E (gE) and either Fas (CD95) or MHC
class II and determined the percentage of gE-positive cells
expressing the various surface markers by flow cytometry.
In duplicate experiments we found that levels of Fas were
significantly reduced on the surface of both immature (P =
0.007) and mature (P = 0.01) DCs (Fig. 2). In contrast,
surface levels of MHC class II were not significantly
changed in either immature or mature VZV-infected DCs.
VZV unable to express ORF47 is impaired for replication in
immature DCs
Previous studies showed that VZV unable to express
ORF47 protein kinase grows to similar titers in human
fibroblasts and melanoma cells, but is impaired for growth in
human T lymphocytes and skin (Heineman and Cohen,
1995; Moffat et al., 1998; Soong et al., 2000). To determine
if ORF 47 is important for VZV infection of DCs, we first
infected human immature DCs with recombinant Oka strain
VZV (ROka) and VZV unable to express ORF47 protein
(ROka47S) in vitro (Fig. 3). Three days after infection, the
cells were stained with monoclonal antibodies to VZV gE
conjugated with fluorescein isothiocyanate (FITC) and
antibody to human CD1a conjugated with phycoerythrin
(PE), and then analyzed by flow cytometry. Approximately
24% of immature DCs (CD1a+) infected with VZV ROka
expressed VZV gE. In contrast, infection of human immature
DCs with VZV unable to express ORF47 (ROka47S)
resulted in only about 8% of DCs expressing VZV gE.
Fig. 2. Surface expression of MHC class II and Fas (CD95) on immature
and mature DCs. DCs were inoculated with uninfected human fibroblasts or
VZV-infected human fibroblasts for 3 days, and the cells were incubated
with monoclonal antibodies to VZV gE and either CD95 or MHC-II. Error
bars show the standard error for two independent experiments.
Fig. 4. Percentage of human immature DCs infected with VZV mutants.
VZV-infected immature DCs were stained as described in Fig. 2 and
analyzed by flow cytometry. Data were obtained from at least three separate
experiments and are presented as the mean T standard error.
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standard error of mean [SEM] of immature DCs infected
with VZV ROka expressed VZV gE (Fig. 4). In contrast,
only 8–10% (mean 9.2 T 1.1% SEM) of immature DCs
infected with ROka47S showed VZV gE. This difference
was statistically significant (P <0.01).
To determine if other VZV genes are important for virus
growth in DCs, we infected immature DCs with four other
viral mutants, ROka66S, ROka10D, ROka32D, and
ROka57D which are unable to express the ORF66,
ORF10, ORF32, and ORF57 proteins, respectively. While
ROka66S is partially impaired for growth in T cells (Moffat
et al., 1998; Soong et al., 2000), the mutant was not
impaired for replication in immature DCs. VZV unable to
express ORF10, ORF32, or ORF57 proteins was not
impaired for growth in immature DCs (Fig. 4). The meanFig. 3. Flow cytometry analysis of VZV gE on human immature DCs infected with
fibroblasts, stained with PE-conjugated mouse anti-human CD1a monoclonal
analyzed by flow cytometry.percentage of DCs expressing VZV gE was 27–40% for the
latter four mutants.
VZV ORF47 is not important for replication of VZV in
mature DCs
Mature DCs are potent antigen-presenting cells that are
important for initiating antiviral immune responses. Morrow
et al. (2003) reported that 15–45% of mature DCs expressed
VZVantigens 4 days after infection with VZV. To determine
which genes are important for VZV infection of mature
DCs, we infected mature DCs with VZV ROka, ROka47S,
and ROka66S. In three experiments, 15–17% (mean 16 T
0.6% [SEM]) of mature DCs infected with ROka expressed
gE, 12–17% (mean 14 T 2.3% [SEM]) of mature DCs
infected with ROka47S expressed gE, and 12–21% (mean
16.7 T 6.7% [SEM]) of mature DCs infected with ROka66S
expressed VZV gE (Fig. 5). There was no significantvirus. Human DCs were inoculated with VZV ROka and ROka47S infected
antibody and FITC-conjugated mouse anti-gE monoclonal antibody, and
Fig. 5. Percentage of VZV-infected human immature and mature DCs determined by flow cytometry. Immature and mature DCs infected with VZV ROka,
ROka47S, or ROka66S were stained as described in Fig. 3 and analyzed by flow cytometry. At least 3 separate experiments were performed and data shown are
the mean T standard error.
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gE for mature DCs infected with ROka, ROka47S, or
ROka66S. Thus, while ORF47 is important for growth of
VZV in immature DCs, the viral protein is not critical for
replication in mature DCs.
VZV unable to express ORF47 is markedly impaired for
transfer of virus from DCs to melanoma cells
To determine if immature DCs infected with VZV
produce infectious virus, infected DCs were cultured in
vitro for 3 days and added to human melanoma cells in 6-
well plates. After incubation at 33 -C for 7 days, the cells
were fixed, stained with crystal violet, and the number of
plaques was counted. As a control, medium washed from
VZV-infected human fibroblasts that had been used to
infect immature DCs was used to infect melanoma cells.
Inoculation of 1000 ROka-infected immature DCs, of
which 32.5 T 7.7% were gE positive, onto melanoma cells
resulted in 18 T 0.5 plaques; inoculation of 1000
ROka47S-infected DCs, of which 9.2 T 1.1% were gE
positive, onto melanoma cells resulted in no plaques
(Table 1). Further dilutions of virus-infected immature
DCs showed a >99% reduction in the number of plaques
in melanoma cells incubated with ROka47S-infected DCs
compared with ROka-infected DCs. Medium obtained
from VZV-infected human fibroblasts did not induce
plaques in melanoma cells. Thus, VZV unable to express
ORF47 is markedly impaired for spread of virus from
DCs to melanoma cells.Table 1
Number of plaques observed on melanoma cell monolayers after
inoculation with VZV-infected DCs
No. of DCs
added
Mean number of plaques on monolayers infected with
ROka-infected DCs ROka47S-infected DCs
105 >300 16.5
104 198 0
103 18 0Replication of VZV unable to express ORF47 in DCs is
blocked between IE (ORF62) and late (gE) gene expression
Immature DCs infected with VZV ROka47S show
reduced expression of gE compared to cells infected with
ROka. This could be due to a failure of ROka47S to infect
DCs, or to a block in virus replication. To determine which
stage in the virus replication cycle is blocked in DCs
infected with ROka47S, we infected immature DCs with
VZV ROka and ROka47S and performed immunofluo-
rescence microscopy with antibodies to a VZV immediate–
early protein (ORF62), a late protein (gE), and a DC marker
(CD1a). Infection of immature DCs with VZV ROka or
ROka47S showed similar numbers of cells (53% or 47%,
respectively) expressing ORF62 protein (Fig. 6). While
numerous DCs infected with ROka expressed gE (41% of
cells), very few cells infected with ROka47S expressed gE
(7% of cells). These results indicate that VZV ROka47S can
infect immature DCs, but that virus replication is blocked
between immediate–early and late gene expression.
Infection of DCs with VZV ROka results in a different
pattern of phosphoproteins compared with ROka47S
VZV ORF47 protein kinase phosphorylates several viral
and cellular proteins including VZV gE, gI, and ORF32,
ORF47, ORF62, and ORF63 proteins as well as casein and
histones (Kenyon et al., 2001, 2002; Ng and Grose, 1992;
Ng et al., 1994; Reddy et al., 1998; Sato et al., 2003). To
determine which proteins are phosphorylated by ORF47
protein in immature DCs, we radiolabeled cells infected
with ROka and ROka47S with [33P]orthophosphate and
performed two-dimensional SDS–PAGE gels to separate
the labeled proteins. Comparison of phosphoproteins in cells
infected with ROka and ROka47S showed bands of 31 kDa
and 35 kDa that were present in ROka-infected DCs, but not
in ROka47S-infected cells (Fig. 7).
Bands of 31 kDa and 35 kDa that were visible by
Coomassie blue staining were excised and mass spectrometry
followed by matrix-assisted laser desorption/ionization
Fig. 6. Immunofluorescent staining of VZV-infected immature DCs with antibodies to DC and VZV proteins. Human immature DCs infected with VZV ROka
and ROka47S were stained with anti-CD1a-FITC (green) and anti-VZV IE62 protein or anti-gE monoclonal antibody followed by Fluor-594 (Red)-labeled
anti-IgG subtype-specific antibodies.
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the H band of l-lactate dehydrogenase, and the 35-kDa band
contained isocitrate dehydrogenase (NAD) subunit alpha.
Unfortunately, since antibodies are not available for these
human proteins, we were unable to confirm that the proteins
are phosphorylated in VZV-infected DCs. Nevertheless, the
molecular weights of these phosphoproteins (31 kDa and
35 kDa) are different than those of the previously described
viral and cellular proteins phosphorylated by ORF47 protein.
Thus,thephosphoproteinsdetectedinDCsinfectedwithROka,
but not ROka47S, are either viral or cellular proteins that have
not been previously reported to be phosphorylated byORF47.Discussion
We have found that VZV unable to express ORF47 is
impaired for growth in immature, but not mature DCs.Fig. 7. Two-dimensional gels of phosphorylated proteins. Human DCs were in
[33P]orthophosphate-labeled proteins were separated by two dimensional SDS–
Circles indicate the position of spots that are present in cells infected with VZV R
31 kDa were visible with Coomassie blue staining and were excised for digestioORF47 is especially important for transfer of virus from
DCs to melanoma cells. The ORF47 protein kinase is
important for phosphorylating at least two proteins in
immature DCs. These experiments demonstrate the impor-
tant role of the ORF47 protein in productive infection of
immature DCs.
We found that infection of immature or mature DCs
with VZV resulted in down-regulation of Fas on the
surface of the cells but had no effect on expression of
MHC class II. The down-regulation of Fas in immature and
mature DCs may help to protect these cells from apoptosis.
Other DNA viruses including myxoma virus (Guerin et al.,
2002) and adenovirus (Shisler et al., 1997) encode proteins
that down-regulate expression of Fas on the surface of
cells.
VZV ORF47 was important for growth of the virus in
immature DCs, but not mature DCs. While VZV lacking
ORF47 could infect immature DCs, as evidenced byoculated with VZV ROka and ROka47S-infected human fibroblasts and
PAGE gels. Molecular masses of proteins are indicated between the gels.
Oka, but not ROka47S. The spot on the right at 35 kDa and on the left at
n by trypsin and subsequent mass spectrometric analysis.
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was a block in infection and very few infected cells
expressed the late viral protein, gE. These findings are
similar to those we previously reported in human T cells
(Soong et al., 2000), in which the ORF47 mutant was able
to infect umbilical cord blood T cells, but was blocked
between immediate–early and late gene expression. In
addition, ORF47 is required for growth of VZV in human
fetal T cells in the SCID-hu mouse (Moffat et al., 1998).
ORF47 is not needed for growth of VZV in melanoma cells
or fibroblasts (Heineman and Cohen, 1995; Moffat et al.,
1998). Since ORF47 encodes a serine–threonine protein
kinase (Ng and Grose, 1992), similar cellular proteins,
which may be substrates for ORF47 protein, might be
required for the growth of VZV in immature DCs and T
cells, but not in mature DCs, melanoma cells, or fibroblasts.
VZV ORF66 was not important for the growth of the
virus in immature or mature DCs. ORF66, like OR47,
encodes a serine– threonine protein kinase. ORF66 is
important for growth of VZV in human T cells both in vitro
(Soong et al., 2000), and in the SCID-hu mouse (Moffat et
al., 1998). In contrast, ORF66 is not necessary for growth of
VZV in human fetal skin, melanoma cells, or fibroblasts
(Heineman et al., 1996; Moffat et al., 1998). Therefore,
human T cells differ from immature DCs in the importance
of the VZV ORF66 protein kinase for VZV replication.
We found that ORF47 is even more important for transfer
of VZV from immature DCs to melanoma cells. VZV
ROka47S was impaired by at least 198-fold for transfer of
virus from DCs to melanoma cells when compared with its
parental virus VZV ROka. Previously, we showed that
ROka47S-infected human T cells were impaired by approx-
imately 1000-fold for transfer of virus to melanoma cells
(Soong et al., 2000). Taken together, these findings suggest
that ORF47 may have a similar role in human T cells and in
immature DCs.
VZV ORF47 protein kinase is required for phosphor-
ylation of at least two proteins in immature DCs. Phospho-
proteins of 31 kDa and 35 kDa in cells infected with ROka,
but not ROka47S, were identified by mass spectrometry
followed by MALDI as l-lactate dehydrogenase H chain
and isocitrate dehydrogenase subunit alpha. A prior study
showed that ORF47 protein was important for phosphor-
ylating proteins of 180, 115, 44, 38, and 22 kDa in
melanoma cells (Heineman and Cohen, 1995). These studies
suggest that ORF47 may phosphorylate different proteins in
immature DCs than in melanoma cells. These differences in
the phosphoprotein profiles of the two cell types may be
important for the marked differences in virus replication in
the cells.
DCs play a critical role for antigen presentation and
antiviral host defense. A number of herpesviruses produc-
tively infect immature DCs (reviewed in Rinaldo and
Piazza, 2004). Infection of immature DCs by cytomegalo-
virus, HSV, or human herpesvirus 6 impairs their maturation
and reduces their ability to stimulate T cell proliferation(Beck et al., 2003; Moutaftsi et al., 2002; Salio et al., 1999;
Smith et al., 2005). Our observations that ORF47 of VZV is
important for virus replication in immature DCs, spread
from these DCs to other cells, and for down-regulation of
Fas in DCs indicate that this viral protein may be
particularly important for VZV to interfere with the immune
response as well as for the virus to be transmitted to other
cells in the host.Materials and methods
Cells and viruses
Human diploid fibroblasts (MRC-5), grown in minimum
essential medium (Gibco, Gaithersburg, MD) supplemented
with 10% heat-inactivated fetal bovine serum and 2 mM l-
glutamine, were used for growth and preparation of virus
stocks. Human melanoma (MeWo) cells were used for virus
transfer assays. Monocytes were obtained from human
peripheral blood and purified by countercurrent elutriation.
VZV recombinant Oka vaccine virus (ROka) (Cohen and
Seidel, 1993), VZV with stop codons in open reading frame
(ORF) 47 (ROka47S) (Heineman and Cohen, 1995) or
ORF66 (ROka66S) (Heineman et al., 1996), or VZV with a
deletion in ORF10 (ROka10D) (Cohen and Seidel, 1994),
ORF32 (ROka32D) (Reddy et al., 1998), or ORF57
(ROka57D) (Cox et al., 1998) have been previously
described.
Monocytes were washed with PBS twice and resus-
pended at 1  106 cells/ml in RPMI containing 10% fetal
bovine serum, 200 U/ml of IL-4 (Peprotech, Rocky Hill,
NJ), 100 ng/ml of GM-CSF (AMGEN, Thousand Oaks,
CA), and cultured at 37 -C. The medium was replaced with
fresh medium containing cytokines on day 3 and day 5. On
day 7, nonadherent cells were collected for infection of
VZV. These cells consisted of >90% immature DCs as
determined by their CD1a+, CD83 phenotype using flow
cytometry. Mature DCs were generated by transferring the
nonadherent immature DCs to 24-well tissue culture plates
at 1  106 cells/well and culturing them for 2 more days in
RPMI containing 10% FCS, 2.5 Ag/ml of lipopolysacchar-
ide (LPS) (Sigma, St. Louis, MO), 100 ng/ml of IFN-g
(R&D Systems, Minneapolis, MN), 200 U/ml of IL-4, and
100 ng/ml of GM-CSF at 37 -C. After 2 days the cells
consisted of >90% mature DCs as determined by their
characteristic dendritic morphology and their cell surface
phenotype (i.e., CD1a+ and CD83+) by flow cytometry.
VZV infection of DCs and transfer of virus to melanoma
cells
Human fibroblasts in 24-well plates were infected with
cells containing 1  105 PFU of VZV per well. At 24–48 h
after infection (when the cells showed ¨80% CPE), 2  106
immature or mature DCs were added to each well of VZV-
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U/ml of IL-4 and 100ng/ml of GM-CSF. The 24-well plates
were centrifuged for 45 min at 150  g at 4 -C and
incubated at 37 -C. After 24 h, the nonadherent DCs were
removed and placed into fresh 24-well plates by gently
washing the human fibroblasts. The new plate was cultured
for 3 more days in fresh medium containing cytokines and
VZV-infected DCs were harvested.
For virus transfer assays, VZV-infected DCs were
collected 4 days after infection and 103–105 infected cells
were added to 6-well plates containing confluent melanoma
cells. After 7 days, melanoma cells were fixed, stained with
crystal violet, and the number of plaques was counted. To
determine whether cell-free VZV was produced, culture
medium from virus-infected DCs was collected 4 days after
infection, inoculated into 6-well plates of confluent mela-
noma cells, and plaques were counted after 7 days.
Staining of cells for flow cytometry and immunofluorescence
VZV-infected DCs were double stained with FITC-
conjugated mouse anti-gE monoclonal antibody (Chemicon
International, Temecula, CA) and PE-conjugated mouse
anti-human CD1a, CD83, CD95 (Fas), or MHC class II
monoclonal antibodies (Caltag Laboratories, Burlingame,
CA) 4 days after infection. A total of 106 cells were stained
with the antibodies and analyzed by flow cytometry using
Cell Quest software (Becton Dickinson).
For immunofluorescence assays, approximately 104 cells
were centrifuged onto glass slides for 5 min at 150  g, air
dried for 30 min, fixed in methanol–acetone (1:1, vol/vol)
at 20 -C for 10 min, and air dried. The cells were stained
with FITC-conjugated mouse anti-human CD1a monoclonal
antibody (isotype IgG2a) (Dako Corporation, Carpinteria,
CA) and anti-VZV immediate–early 62 protein antibody
(IgG1) (Chemicon International) or anti-VZV late gE
protein antibody (IgG2b), followed by Alexa Fluor 594-
labeled goat anti-mouse isotype-specific (IgG1 or IgG2b)
antibodies (Molecular Probes, Eugene, OR). Cells were
incubated with antibodies for 1 h at 37 -C, washed in PBS,
and visualized by fluorescence microscopy.
Cell labeling with radiolabeled orthophosphate and
2-dimensional gel electrophoresis
VZV-infected and mock-infected DCs were collected 4
days after infection and labeled with [33P]orthophosphate for
4 h. After labeling, the cells were lysed in RIPA buffer
(10 mM Tris, pH 8.0, 100 mM NaCl, 1 mM EDTA, 1%
Nonidet P-40, 0.5% deoxycholic acid, 0.1% SDS, 1 mM
PMSF). Cell lysates were collected, protein concentrations
were determined, and 30 Ag of protein was subjected to 2-
dimensional gel electrophoresis. The first dimension (iso-
electric focusing) was on a 2% polyacrylamide–SDS tube gel
(pH 3.5–10 ampholytes), and the second dimension was on a
10% polyacrylamide–SDS slab gel. Gels were stained withCoomassie blue, dried, and autoradiography was performed.
[33P]-labeled protein spots present in VZV ROka, but absent
in ROka47S infected cell lysates were cut from the gel and
mass spectrometry followed by MS-MALDI was performed.
Proteins were identified by MS-Fit protein matching.Acknowledgments
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